Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$806M |
| 2 |
AbbVie
ABBV
|
+$481M |
| 3 |
T-Mobile US
TMUS
|
+$464M |
| 4 |
Kroger
KR
|
+$430M |
| 5 |
Baidu
BIDU
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.35B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.26B |
| 3 |
S
Sprint Corporation
S
|
+$675M |
| 4 |
Amgen
AMGN
|
+$488M |
| 5 |
Humana
HUM
|
+$450M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.76% |
| 2 | Technology | 16.41% |
| 3 | Consumer Staples | 10.58% |
| 4 | Consumer Discretionary | 10.13% |
| 5 | Communication Services | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CSW
1251
CSW Industrials
CSW
$5.62B
| $9.5M | 0.01% |
137,500
-19,700
| -13% | -$1.33M |
|
|
ALSK
1252
DELISTED
Alaska Communications Systems
ALSK
| $9.49M | 0.01% |
3,402,086
+445,124
| +15% | +$1.01M |
|
1253
Banco Bradesco
BBD
$33.9B
| $9.49M | 0.01% |
+3,013,579
| New | +$9.17M |
|
1254
Diamondback Energy
FANG
$57.1B
| $9.49M | 0.01% |
226,889
-605,200
| -73% | -$24.7M |
|
|
EARN
1255
Ellington Residential Mortgage REIT
EARN
$165M
| $9.49M | 0.01% |
921,000
+22,700
| +3% | +$204K |
|
1256
Magna International
MGA
$18.6B
| $9.46M | 0.01% |
212,484
-206,200
| -49% | -$8.15M |
|
1257
SouthState Bank Corp
SSB
$10.8B
| $9.46M | 0.01% |
198,464
+172,382
| +661% | +$9M |
|
|
ORC
1258
Orchid Island Capital
ORC
$1.33B
| $9.45M | 0.01% |
401,259
-141,480
| -26% | -$2.82M |
|
1259
White Mountains Insurance
WTM
$5.09B
| $9.41M | 0.01% |
10,600
-600
| -5% | -$541K |
|
1260
Eagle Materials
EXP
$6.38B
| $9.41M | 0.01% |
134,000
+14,800
| +12% | +$931K |
|
1261
Protagonist Therapeutics
PTGX
$9.89B
| $9.4M | 0.01% |
532,300
-43,100
| -7% | -$541K |
|
|
LGF.B
1262
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
| $9.36M | 0.01% |
1,370,234
+66,900
| +5% | +$462K |
|
1263
Tradeweb Markets
TW
$22.3B
| $9.3M | 0.01% |
159,966
-617,081
| -79% | -$35.5M |
|
1264
Enel Chile
ENIC
$6.2B
| $9.3M | 0.01% |
2,466,173
+391,216
| +19% | +$1.48M |
|
1265
Conduent
CNDT
$247M
| $9.29M | 0.01% |
3,888,858
+959,658
| +33% | +$2.23M |
|
|
STAY
1266
DELISTED
Extended Stay America, Inc. Paired Share Unit
STAY
| $9.29M | 0.01% |
830,290
+73,190
| +10% | +$767K |
|
1267
Old Second Bancorp
OSBC
$1.32B
| $9.28M | 0.01% |
1,192,925
+46,700
| +4% | +$346K |
|
1268
Regis Corp
RGS
$70M
| $9.28M | 0.01% |
56,720
-39,620
| -41% | -$7.43M |
|
1269
Evercore
EVR
$12B
| $9.24M | 0.01% |
156,900
-150,800
| -49% | -$8.2M |
|
|
ZUO
1270
DELISTED
Zuora, Inc.
ZUO
| $9.23M | 0.01% |
723,700
+81,200
| +13% | +$904K |
|
|
GLIBA
1271
DELISTED
GCI Liberty, Inc. Class A Common Stock (DE)
GLIBA
| $9.19M | 0.01% |
129,210
-1,000
| -0.8% | -$64.1K |
|
|
CMRX
1272
DELISTED
Chimerix, Inc.
CMRX
| $9.17M | 0.01% |
2,958,289
-291,724
| -9% | -$755K |
|
1273
Dime Commercial Bancshares
DCOM
$1.82B
| $9.17M | 0.01% |
401,500
-4,859
| -1% | -$99.8K |
|
1274
Selective Insurance
SIGI
$5.59B
| $9.15M | 0.01% |
173,594
+37,800
| +28% | +$1.91M |
|
1275
Columbus McKinnon
CMCO
$547M
| $9.11M | 0.01% |
272,385
-16,715
| -6% | -$461K |
|
Similar funds
Jim Simons's Q2 2020 Portfolio in Review
As of Q2 2020, Jim Simons held 3,987 positions worth $116B, up 13% from $103B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Jim Simons withdrew a net $8.24B in Q2 2020, closing 596 positions and reducing 1,366 holdings. Its most notable exit was Allergan plc, an estimated $1.26B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 26% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Jim Simons opened a new position in Uber worth $187M.
- Jim Simons's largest Q2 2020 buy was Uber: 6,030,316 shares worth $187M.
- Jim Simons added most to Zoom in Q2 2020, an estimated $806M increase.
- Jim Simons's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.35B.
- Jim Simons fully exited Allergan plc in Q2 2020, selling an estimated $1.26B.
- Jim Simons's ten largest holdings make up 14% of its $116B portfolio in Q2 2020.
- Jim Simons opened 584 new positions and closed 596 in Q2 2020.
- Jim Simons's portfolio value rose 13% quarter-over-quarter to $116B.
Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.